Filtration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010



Similar documents
Special Resource. Drugs to be Used with a Filter for Preparation and/or Administration

Hydration, IV Infusions, Injections and Vaccine Charge Process

Monoclonal antibody (mab) products are currently a fast

INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES

MEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.

Analysis of hospital pharmaceuticals

Meridian Health Plan Drugs Covered under the Medical Benefit* Updated 09/2015 PA Required

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

HCPCS REQUIRING CORRESPONDING NDC CODES

MEDICAL BENEFIT BOOKLET

Sector Analysis February 4, 2016

2006 CPT Coding and Documentation for Drug Administration

Drugs covered under Medicare Part B or Part D

Table I: FOR CRITICAL ACCESS HOSPITAL, HOSPITAL, OFFICE-BASED SURGERY

New York Methodist Hospital Drug Protocols

Fourth Quarter 2014 Provider Connection

Medical Policy and Clinical Guideline Updates

HCPCS J Codes Last Updated January 2014

Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment

Classification of Hazardous Drugs by NIOSH

Cost Differences in Cancer Care Across Settings

Monoclonal Antibody. By Dr. Adel Gabr

NOTICES DEPARTMENT OF HEALTH

Quantum of Effectiveness Evidence in FDA s Approval of Orphan Drugs

Coverage and Pricing. of Drugs That Can Be Covered Under. Part B and Part D

THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005

Monoclonal Antibodies

NOTICES. Approved and Required Medications Lists for Emergency Medical Services Agencies and Emergency Medical Services Providers

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

PPP 1. Continuation of a medication to ensure continuity of care

Improvement in Quality of Life of Rheumatoid Arthritis Patients on Biologic Therapy

Rheumatoid Arthritis Medicines. A Guide for Adults

ICORE Healthcare: Injectable Drug Utilization Management Program Overview for EmblemHealth Providers. May 1, 2012

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

In this issue Page. anthem.com. Important phone numbers. May 2012

PHARMACY TECHNICIAN COURSE DESCRIPTIONS

Pain management for cancer patients Acute Ischemic Stroke. Hemophilia, Von willebrand disease & Bleeding disorders. Infectious Disease

Biologic Treatments for Rheumatoid Arthritis

Basic Medication Administration Exam LPN/LVN (BMAE-LPN/LVN) Study Guide

Self-injectable, infused and oral specialty drugs 2014 Aetna Specialty CareRx SM Benefits Plan Drug List

Order Phenytoin dilantin ivpb rate when to order phenytoin level dilantin 30 mg

The Future of Monoclonal Antibodies Therapeutics: Innovation in Antibody Engineering, Key Growth Strategies and Forecasts to 2011

Medicare coverage of and payment for home infusion therapy

An introduction to High Risk Medications

Basic Medication Administration Exam RN (BMAE-RN) Study Guide

Pharmaceuticals utilized in stem cell transplant

Items Covered Benefit for Preferred Vendor Contact Information. Medicaid ONLY Integra Phone

Cardiac Procedure: Outpatient Office Inpatient Emergent/Urgent Diagnostic Catheterization Required Required Not Not required

HIGHLY SPECIALISED DRUGS PROGRAM AND HERCEPTIN PROGRAM. Western Australia Administrative Guidelines

Rheumatic Diseases, Psoriasis, and Crohn s Disease

MEDICATION MANUAL Policy & Procedure

Calculations Practice Problems

INPATIENT SERVICES Commercial Medicare. Notification required only, as soon as possible, but no later than 24 hours

Commercial Insight: Disease Modification in Rheumatoid Arthritis - Market awaits game changing therapies and strategies

Uses of 2D gel electrophoresis in recombinant protein production. Kendrick Laboratories, Inc

Alameda Alliance for Health SPECIALTY PHARMACY PROGRAM FOR ALLIANCE MEDI-CAL AND GROUP CARE MEMBERS PROGRAM DESCRIPTION

Synagis (Palivizumab)

Commonwealth of Massachusetts Executive Office of Health and Human Services Office of Medicaid

drugs in development CuraScript Specialty Pharmacy Management Guide & Trend Report

Good Practice Guidance: The safe management of controlled drugs in care homes

P to the uninsured population is

2016 MDwise HIP Medical Services that Require Prior Authorization

Patient Assistance Programs

Therapy Trends: Rheumatoid Arthritis -- KOL Insight Module

Development of the market of special care drugs

Patient Assistance Programs

Cancer Immunotherapy FREE PATIENT RESOURCE. TUnderstanding. take. one. Monoclonal Antibodies. Second Edition. Adoptive T Cell Transfer

MEDICATION DELIVERY. Specialty Pharmaceuticals & Fluid Systems Catalogue. March, Helping to Save and Sustain Lives

I.V. ADMINISTRATION GUIDELINES All IV meds must be administered by IV pump. Diluent Amount Over (min.) NO D5W 200mL. 500ml. 1000ml.

Medication Calculation Practice Problems

Authorized by the U.S. District Court for the District of Massachusetts

Evaluating a benchmarking database and identifying cost reduction opportunities by diagnosis-related group

GUIDE TO THE PREVENTION OF CHEMOTHERAPY MEDICATION ERRORS

APC Status Description S LEVEL I PHOTOCHEMOTHERAPY T LEVEL I FINE NEEDLE BIOPSY/ASPIRATION T BONE MARROW BIOPSY/ASPIRATION T

Corporate Medical Policy

Medicines for Psoriatic Arthritis. A Review of the Research for Adults

ALS INTERFACILITY TRANSFERS. SUPERSEDES: January 8, 2009

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Special Authorization

Pharmacy and Nursing Collaborate to Improve the Patient Experience Communication about Medications

Inter-facility Patient Transfers

United Healthcare Medicare Solutions

Ted Quiroz Director, Global Clinical Supply Chain Amgen Inc.

Kaposi Sarcoma. What is Kaposi sarcoma? Types of Kaposi sarcoma. Epidemic (AIDS-related) Kaposi sarcoma

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Special Types of Intravenous Calculations

Effective: July 28, Arizona Prior Authorization Requirements Health Net Access, Inc.

5/21/2012. JCAHO National Patient Safety Goal: Maintain and communicate accurate patient medication information.

Implications of dose rounding intravenous chemotherapy at a community based hospital

REFERENCE CODE GDHC503DFR PUBLICAT ION DATE DECEMBER 2014 METHOTREXATE (RHEUMATOID ARTHRITIS) - FORECAST AND MARKET ANALYSIS TO 2023

MEDICATION GUIDE. ACTEMRA (AC-TEM-RA) (tocilizumab) Solution for Intravenous Infusion

Brand Generic J-Code Covered Uses Required Medical Information and Criteria

Transcription:

iltration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 8/2010 SUMMARY O CHANGES: Green = Added from literature (Lexi-Comp, Micromedex, pkg inserts) Yellow = Confirmed in literature = Removed IV Medications Requiring iltration During Administration ORMULARY Drug Name Generic (Brand) ilter Size (micron) STATUS Abatacept (Orencia) 0.22 to 1.2 Abciximab (ReoPro) 0.22 Agalsidase Beta (abrazyme) 0.22 15 dispensed with Albumin * filter tubing Alglucerase (Ceredase) 0.22 Alglucosidase Alfa (Myozyme) 0.22 Alpha-1 Proteinase Inhibitor, Human (Zemaira) 5 Amiodarone Hydrochloride (Cordarone) 0.22 Restricted Amphotericin B Liposomal (Ambisome) 1 Antithymocyte Globulin, Rabbit (Thymoglobulin) 0.22 Asparaginase (Elspar) 5 200 tubing located Blood Solutions on floors Botulinism Immune Globulin, Human (BabyBIG) 18 Cetuximab (Erbitux) 0.22 Restricted Cytomegalovirus Immune Globulin (CytoGam) 15 or 0.22 Diazepam (Valium) 0.22 or 0.5 Digoxin Immune ab (Digibind) 0.22 Etoposide (VePesid,Toposar) 0.22 erumoxides (eridex IV) 5 RATIONALE May use in-line filter with mean pore diameter 1 Galsulfase (Naglazyme) 0.22 Ganciclovir (Cytovene) 0.22 iltration

Gemtuzumab Ozogamicin (Mylotarg) 1.2 Ibritumomab (Zevalin) 0.22 Idursulfase (Elaprase) 0.22 Imiglucerase (Cerezyme) 0.22 15 dispensed with Immune Globulin (Polygam, Gammagard) filter tubing 1.2 0.22 dispensed with non- Infliximab (Remicade) PVC tubing 0.22 to 1.2 non- Ixabepilone (Ixempra) PVC tubing Lansoprazole (Prevacid) 0.22 (oral only) Laronidase (Aldurazyme) 0.22 Lipids 1.2 dispensed with filter tubing Lorazepam (Ativan) 0.22 Lymphocyte Immune Globulin, Antithymocyte Globulin, Equine (Atgam) 0.22 to 1 Mannitol (Osmitrol) 0.22 Muromonab-CD3 (Orthoclone OKT 3) 0.22 0.22 non-pvc Paclitaxel (Taxol) tubing Panitumumab (Vectibix) 0.22 Parenteral Nutrient Solutions (without lipids) 0.22 Parenteral Nutrient Solutions (with lipids) 1.2 5 Phenytoin (Dilantin) 0.22 5 non-pvc Temsirolimus (Torisel) tubing Total Parenteral Nutrition (without lipids) 0.22 Urokinase (Abbokinase) 0.45 0.22 Vaccinia Immune Globulin (CNJ-016) 0.22 Verteporfin (Visudyne) 1.2 requirement not stated in Lexi-Comp, Micromedex, or pkg insert. Gammagard does not require filtration per pkg insert; Polygam DSC. Moved under TPN (see below). Not available at UK. * Recommended, but the filtration of albumin in not required in the NICU.

IV Medications NOT Requiring iltration During Administration Drug Name Generic (Brand) Amphotericin B (ungizone) Amphotericin B Lipid Complex (Abelcet) Amphotericin B Liposomal (Ambisome) Daunorubicin Citrate Liposomal (Daunoxome) Denileukin Diftitox (ONTAK) Digitoxin Doxorubicin Hyodrochloride Liposomal (Doxil) Etanercept (Enbrel) Insulin Preparations Morphine Sulfate Extended-Release Liposomal (DepoDur) Nesiritide (Natrecor) Nitroglycerin Palifermin (Kepivance) Plicamycin (Mithracin) Rasburicase (Elitek) Sargramostim (Leukine) Teniposide (Vumon) Vincristine (Oncovin) ORMULARY STATUS Restricted Restricted Moved to list of meds requiring filter per pkg insert (says it may be used ). References: 1. Micromedex. 2. Am J HSP Vol 58; Jan 15, 2001. 3. Chen & Martinez; Am J HSP; 1998;55:1313-14. 4. Lexi-Comp. IVfiltration.doc 9/2004 P225

iltration Guidelines for the Administration of Intravenous Medications UK Pharmacy Services Revised 10/2008 IV Medications Requiring iltration During Administration DRUG NAME [Generic (Brand)] ILTER SIZE [Micron] Abatacept (Orencia) 0.22 to 1.2 Abciximab (ReoPro) 0.22 Agalsidase Beta (abrazyme) 0.22 Albumin * 15 dispensed with filter tubing Alglucerase (Ceredase) 0.22 Alglucosidase Alfa (Myozyme) 0.22 Alpha-1 Proteinase Inhibitor, Human (Zemaira) 5 Amiodarone Hydrochloride (Cordarone) 0.22 Amphotericin B Liposomal (Ambisome) 1 Antithymocyte Globulin, Rabbit (Thymoglobulin) 0.22 Asparaginase (Elspar) 5 Blood Solutions 200 tubing located on floors Botulinism Immune Globulin, Human (BabyBIG) 18 Cetuximab (Erbitux) 0.22 Cytomegalovirus Immune Globulin (CytoGam) 15 or 0.22 Diazepam (Valium) 0.22 or 0.5 Digoxin Immune ab (Digibind) 0.22 Etoposide (VePesid,Toposar) 0.22 erumoxides (eridex IV) 5 Galsulfase (Naglazyme) 0.22 Gemtuzumab Ozogamicin (Mylotarg) 1.2 Ibritumomab (Zevalin) 0.22 Idursulfase (Elaprase) 0.22 Imiglucerase (Cerezyme) 0.22 Infliximab (Remicade) 1.2 dispensed with non-pvc tubing Ixabepilone (Ixempra) 0.22 to 1.2 non-pvc tubing Lansoprazole (Prevacid) 0.22 Laronidase (Aldurazyme) 0.22

Lipids Lorazepam (Ativan) 0.22 Lymphocyte Immune Globulin, Antithymocyte Globulin, Equine (Atgam) 0.22 to 1 Mannitol (Osmitrol) 0.22 Muromonab CD3 (Orthoclone OKT 3) 0.22 Paclitaxel (Taxol) Panitumumab (Vectibix) 0.22 Phenytoin (Dilantin) 0.22 1.2 dispensed with filter tubing 0.22 non-pvc tubing Temsirolimus (Torisel) 5 non-pvc tubing Total Parenteral Nutrition (without lipids) 0.22 Urokinase (Abbokinase) 0.45 Vaccinia Immune Globulin (CNJ-016) 0.22 Verteporfin (Visudyne) 1.2 * Recommended, but the filtration of albumin in not required in the NICU.

IV Medications NOT Requiring iltration During Administration DRUG NAME Generic (Brand) Amphotericin B (ungizone) Amphotericin B Lipid Complex (Abelcet) Daunorubicin Citrate Liposomal (Daunoxome) Denileukin Diftitox (ONTAK) Digitoxin Doxorubicin Hyodrochloride Liposomal (Doxil) Etanercept (Enbrel) Insulin Preparations Morphine Sulfate Extended-Release Liposomal (DepoDur) Nesiritide (Natrecor) Nitroglycerin Palifermin (Kepivance) Plicamycin (Mithracin) Rasburicase (Elitek) Sargramostim (Leukine) Teniposide (Vumon) Vincristine (Oncovin) References: 1. Micromedex. 2. Am J HSP Vol 58; Jan 15, 2001. 3. Chen & Martinez; Am J HSP; 1998;55:1313-14. 4. Lexi-Comp. IVfiltration.doc 9/2004 P225